Royal Hobart Hospital

Public research footprint of Royal Hobart Hospital, compiled from the ClinicalTrials.gov public registry.

246

Registered studies

Active

Recruiting now

112

Completed

Stopped or withdrawn

Most-studied conditions

Pulmonary Arterial Hypertension · Follicular Lymphoma · Metastatic Non-small Cell Lung Cancer With MTAP Deletion · Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Recently updated registry entries

NCT07218029 — A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension… (Recruiting)
NCT00310180 — Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have… (Active Not Recruiting)
NCT03748641 — A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Royal Hobart Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.